Eva Van Braeckel
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Antifungal resistance and susceptibility
Papers in
-
- Cystic Fibrosis Research Advances 16
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Inhalation and Respiratory Drug Delivery 2
-
- Antifungal resistance and susceptibility 8
- Tuberculosis Research and Epidemiology 3
- Co-authors
- Bart N. Lambrecht (3 shared papers)Pieter Depuydt (6 shared papers)Eric Derom (2 shared papers)Sebastiaan Dhont (2 shared papers)Geert Leroux‐Roels (6 shared papers)Karin Weening (1 shared paper)Yannick Vande Weygaerde (14 shared papers)Cornelus C. Hermsen (1 shared paper)
- Journals
- Journal of Cystic Fibrosis (5 papers)Journal of Antimicrobial Chemotherapy (2 papers)Frontiers in Immunology (2 papers)Respiratory Research (2 papers)Vaccine (2 papers)
- Partner nations
- BelgiumNetherlandsUnited Kingdom
In The Last Decade
Eva Van Braeckel
59 papers receiving 1.2k citations
Eva Van Braeckel's Hit Papers
Peers
Comparison fields: 5 of 103
- Infectious Diseases 308
- Critical Care and Intensive Care Medicine 54
- Virology 54
- Pulmonary and Respiratory Medicine 329
- Neurology 118
Countries citing papers authored by Eva Van Braeckel
This map shows the geographic impact of Eva Van Braeckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Van Braeckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Van Braeckel more than expected).
Fields of papers citing papers by Eva Van Braeckel
This network shows the impact of papers produced by Eva Van Braeckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Van Braeckel. The network helps show where Eva Van Braeckel may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Van Braeckel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The pathophysiology of ‘happy’ hypoxemia in COVID-19 Hit paper breakdown → | 2020 | 338 |
| 2 | 2013 | 111 | |
| 3 | A safety study of oral tangeretin and xanthohumol administration to laboratory mice. | 2005 | 90 |
| 4 | 2021 | 70 | |
| 5 | 2011 | 51 | |
| 6 | 2021 | 43 | |
| 7 | 2020 | 39 | |
| 8 | 2019 | 38 | |
| 9 | 2019 | 36 | |
| 10 | 2012 | 28 | |
| 11 | 2020 | 26 | |
| 12 | 2018 | 26 | |
| 13 | 2013 | 26 | |
| 14 | 2022 | 17 | |
| 15 | 2020 | 16 | |
| 16 | 2024 | 15 | |
| 17 | 2021 | 15 | |
| 18 | 2020 | 14 | |
| 19 | 2023 | 14 | |
| 20 | 2018 | 13 |
About Eva Van Braeckel
Eva Van Braeckel is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Epidemiology, Virology and Immunology, having authored 61 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (16 papers), Antifungal resistance and susceptibility (8 papers), Mycobacterium research and diagnosis (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Fungal Infections and Studies (4 papers), HIV Research and Treatment (4 papers), Tuberculosis Research and Epidemiology (3 papers) and Inhalation and Respiratory Drug Delivery (2 papers). The work is most often cited by research in Infectious Diseases (308 citations), Critical Care and Intensive Care Medicine (54 citations), Virology (54 citations), Pulmonary and Respiratory Medicine (329 citations) and Neurology (118 citations). Eva Van Braeckel has collaborated with scholars based in Belgium, Netherlands and United Kingdom. Frequent co-authors include Bart N. Lambrecht, Pieter Depuydt, Eric Derom, Sebastiaan Dhont, Geert Leroux‐Roels, Karin Weening, Yannick Vande Weygaerde, Cornelus C. Hermsen, Robert W. Sauerwein and Geert‐Jan van Gemert. Their work appears in journals such as Journal of Cystic Fibrosis, Journal of Antimicrobial Chemotherapy, Frontiers in Immunology, Respiratory Research and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.